Association between Interlukin-6 (IL-6), Interlukin-10 (IL-10) and depression in patients undergoing hematopoietic stem cell transplantation

International Journal of Hematology-Oncology and Stem Cell Research

Volumn 9, Issue 2, 2015, Pages 26-33

  Tavakoli Ardakani, Maria ^a   Mehrpooya, Maryam ^b   Mehdizadeh, Mahshid ^a   Hajifathali, Abbas ^c   Abdolahi, Alireza ^d  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Depression; Hematopoietic stem cell transplantation; Hs CRP; IL 6; Inflammatory cytokines

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6;

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE;

EID: 84927515298     PISSN: 17351243     EISSN: 20082207     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med; 2006. 354: 1813-1826.
2. Ustun TB, Sartorius N. Mental Illness in General Healthcare: An International Study. London: John Wiley &Sons;1995.p.2264.
3. Farber DM, Wienerman BH, Kuypers JA. Psychosocial distress in oncology outpatients. J Psychosocial Oncol; 1984.2:109-118.
4. Trask PC, Paterson AG, Hayasaka S, et al. Psychosocial characteristics of individuals with non-stage IV melanoma. J Clin Oncol; 2001. 19: 2844-2850.
5. Stefanek ME, Derogatis LP, Shaw A. Psychological distress among oncology outpatients. Psychosomatics; 1987.28:530-539.
6. Lee SJ, Loberiza FR, Rizzo JD, et al. Optimistic expectations and survival after hematopoieticnstem cell transplantation. Biol Blood Marrow Transplan;t 2003.9: 389-396.
7. Loberiza Jr FR, Rizzo JD, Bredeson CN, et al. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol; 2002.20:2118-2126.
8. Kiecolt-Glaser JK, Glaser R. central pathways to morbidity and mortality. J Psychosom Res; 2002.53: 873 876.
9. Braamse AM, Gerrits MM, van Meijel B, et al. Predictors of health-related quality of life in patients treated with auto-and allo-SCT for hematological malignancies. Bone Marrow Transplant; 2012.47:757-69.
10. McGregor BA, Syrjala KL, Dolan ED, et al .The effect of pre-transplant distress on immune reconstitution among adult autologous hematopoietic cell transplantation patients. Brain Behav Immun;2012. 30: S142-S148.
11. Costanzo ES, Juckett MB, Coe CL. Biobehavioral influences on recovery following hematopoietic stem cell transplantation. Brain Behav Immun;2012. 30: S68-S74.
12. Knight JM, Lyness JM, Sahler OJZ, et al. Psychosocial factors and hematopoietic stem cell transplantation: Potential biobehavioral pathways. Psychoneuro endocrinology; 2013.38: 2383-2393.
13. Hoodin F, Uberti JP, Lynch TJ, et al. Do negative or positive emotions differentially impact mortality after adult stem cell transplant? Bone Marrow Transplant; 2006.38,255-264.
14. Moylan S, Maes M, Wray NR, et al. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications. Mol Psychiatry;2013.18,595-606.
15. Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry; 2010.1:446-57.
16. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med; 2009.71:171-86.
17. Liu Y, Ho RC, Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord;2012. 139:230-9.
18. Mesquita AR, Correia-Neves M, Roque S, et al. IL-10 modulates depressive-like behavior. J Psychiatr Res; 2008.43:89-97.
19. Roque S, Correia-Neves M, Mesquita AR, et al. Interleukin-10: a key cytokine in depression? Cardiovasc. Psychiatry Neurol; 2009.2009:1-5.
20. Schots R, Kaufman L, Van Riet I, et al. Monitoring of Creactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality. Bone Marrow Transplant; 1998. 22:79-85.
21. Cavet J, Dickinson AM, Norden J, et al. Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood; 2001.98:1594-600.
22. Symington FW, Symington BE, Liu PY, et al. The relationship of serum IL-6 levels to acute graft versus-host disease and hepatorenal disease after human bone marrow transplantation. Transplantation; 1992.54:457-62.
23. Tegg EM, Griffiths AE, Lowenthal RM, et al Association between high interleukin-6 levels and adverse outcome after autologous haemopoietic stem cell transplantation. Bone Marrow Transplant; 2001.28(10):929-33.
24. Holler E, Roncarolo MG, Hintermeier-Knabe R et al. Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation. Bone Marrow Transplant; 2000. 25: 237-241.
25. Montazeri A, Vahdaninia M, Ebrahimi M, et al.The Hospital Anxiety and Depression Scale (HADS): translation and validation study of the Iranian version. Health Qual Life Outcomes; 2003. 28;1:14.
26. Syrjala KL, Chapko MK, Vitaliano PP, et al. Recovery after allogeneic marrow transplanation: prospective study of predictors of long-term physical and psychosocial functioning. Bone Marrow Transplant; 1993. 11:319-327.
27. Andrykowski MA, Bruehl S, Brady MJ, et al. Physical and psychosocial status of adults one-year after bone marrow transplantation: a prospective study. Bone Marrow Transplant; 1995. 15: 837-844.
28. McQuellon RP, Russell GB, Rambo TD, et al. Quality of life and psychological distress of bone marrow transplant recipients: the ‘time trajectory’ to recovery over the first year. Bone Marrow Transplant; 1998. 21: 477-486.
29. Maheri Azar R, Nikoogoftar M, Salehi S, et al. Anxiety and Depression in pre-and-post-Hematopoietic Stem Cell Transplants in SCT Center, Shariati Hospital, Tehran, Iran. Int J Hematol Oncol Stem Cell Res; 2010. 4:17-21.
30. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol; 2006. 27; 24-31
31. Alesci S, Martinez PE, Kelkar S, et al. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm and loss of physiological complexity in its secretion: clinical implications. J Clin Endocrinol Metab;2005.90:2522-2530.
32. Vogelzang N, Duivis HE, Beekman AT, et al. Association of depressive disorders, depression characteristics and antidepressant medication with inflammation. Transl Psychiatry; 2012.2:e79.
33. Hannestad J, DellaGioia N, Bloch M. The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuro psycho pharmacology;2011.36:2452-9.
34. Imamura M, Hashino S, Kobayashi H, et al. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factoralpha in graft-versus-host disease. Bone Marrow Transplant; 1994.13: 745-751.
35. Testa U, Martucci R, Rutella S, et al. Autologous stem cell transplantation: release of early and late acting growth factors relates with hematopoietic ablation and recovery. Blood; 1994. 84: 3532-3539.
36. Valkanova V, Ebmeier KP, Allan CL. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord; 2013. http://dx.doi.org?10.1016/j.jad.2013.06.004.
37. Ford DE, Erlinger TP. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med; 2004.10:1010-4.
38. Ma Y, Chiriboga DE, Pagoto SL, et al. Association between Depression and C-Reactive Protein. Cardiol Res Pract;2010.2011:286509.
39. Dhabhar FS, Burke HM, Epel ES, et al. Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression. J Psychiatr Res; 2009. 43(11): 962-9.
40. Simon NM, McNamara K, Chow CW, et al. A detailed examination of cytokine abnormalities in Major Depressive Disorder. European Neuro psychopharmacology; 2008.18: 230-3.
41. Huang TL, Lee CT. T-helper 1/T-helper 2 cytokine imbalance and clinical phenotypes of acute-phase major depression. Psychiatry and Clinical Neurosciences; 2007.61:415-20.
42. O’Brien SM, Scully P, Fitzgerald P, et al. Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res; 2007.41:326-31.
43. Fang Y, Sharp GC, Braley-Mullen H. Interleukin-10 promotes resolution of granulomatous experimental autoimmune thyroiditis. Am J Pathol; 2008.172:1591-602.
44. Ogawa Y, Duru EA, Ameredes BT. Role of IL-10 in the resolution of airway inflammation. Curr Mol Med; 2008.8:437-45.
45. Taraz M, Khatami MR, Gharekhani A, et al. Relationship between a pro-and anti-inflammatory cytokine imbalance and depression in haemodialysis patients. Eur Cytokine Netw; 2012.23:179-86.